Resveratrol treatment regulated Bcl-xL and NF-κB protein levels in an in vitro Alzheimer’s disease model, and protected rat pheochromocytoma cells, PC12, against Aβ-induced oxidative stress [122]. The gene discussed is BCL2L1; the disease is Alzheimer disease.